GA

Gilles Avenard

Europe, Ile-de-France, France, Paris

Description

Board member or advisor for several biotech companies ; co-founder and COO of BioAlliance Pharma SA – ONXEO (NYSE EURONEXT) until 2010. Gill...

Investor Profile

Gilles Avenard has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gilles Avenard frequently co-invest with?

MF
Europe, Lombardia, Italy, Milan
Co-Investments: 1
UI Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 1

Which angels does Gilles Avenard often collaborate with?

AM
Europe, Bourgogne, France, Dijon
Shared Deals: 1

What are some of recent deals done by Gilles Avenard?

Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityMar 15, 2024
Amount Raised: $8,712,224